These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8306323)

  • 21. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
    J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative allelotype of early and advanced stage non-small cell lung carcinomas.
    Shiseki M; Kohno T; Adachi J; Okazaki T; Otsuka T; Mizoguchi H; Noguchi M; Hirohashi S; Yokota J
    Genes Chromosomes Cancer; 1996 Oct; 17(2):71-7. PubMed ID: 8913723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer.
    Kim SK; Ro JY; Kemp BL; Lee JS; Kwon TJ; Fong KM; Sekido Y; Minna JD; Hong WK; Mao L
    Cancer Res; 1997 Feb; 57(3):400-3. PubMed ID: 9012464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion mapping of chromosome 2 in human lung carcinoma.
    Otsuka T; Kohno T; Mori M; Noguchi M; Hirohashi S; Yokota J
    Genes Chromosomes Cancer; 1996 Jun; 16(2):113-9. PubMed ID: 8818658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer.
    Takei K; Kohno T; Hamada K; Takita J; Noguchi M; Matsuno Y; Hirohashi S; Uezato H; Yokota J
    Cancer Res; 1998 Aug; 58(16):3700-5. PubMed ID: 9721881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
    Cairns P; Tokino K; Eby Y; Sidransky D
    Cancer Res; 1995 Jan; 55(2):224-7. PubMed ID: 7812948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer.
    Wick W; Petersen I; Schmutzler RK; Wolfarth B; Lenartz D; Bierhoff E; Hümmerich J; Müller DJ; Stangl AP; Schramm J; Wiestler OD; von Deimling A
    Oncogene; 1996 Mar; 12(5):973-8. PubMed ID: 8649814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast.
    Tran Y; Benbatoul K; Gorse K; Rempel S; Futreal A; Green M; Newsham I
    Oncogene; 1998 Dec; 17(26):3499-505. PubMed ID: 10030674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer.
    Fong KM; Kida Y; Zimmerman PV; Ikenaga M; Smith PJ
    Cancer Res; 1995 Oct; 55(19):4268-72. PubMed ID: 7671234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma.
    Huang DP; Lo KW; van Hasselt CA; Woo JK; Choi PH; Leung SF; Cheung ST; Cairns P; Sidransky D; Lee JC
    Cancer Res; 1994 Aug; 54(15):4003-6. PubMed ID: 8033130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human epithelial ovarian cancer allelotype.
    Cliby W; Ritland S; Hartmann L; Dodson M; Halling KC; Keeney G; Podratz KC; Jenkins RB
    Cancer Res; 1993 May; 53(10 Suppl):2393-8. PubMed ID: 8485726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
    Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
    Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of heterozygosity loss in the long arm of chromosome 5 (5q21) in small cell carcinoma of the lung].
    Sánchez Céspedes M; López Cabrerizo MP; Moreno I; Ariza A; Monzó M; Rosell R
    Med Clin (Barc); 1997 May; 109(1):1-5. PubMed ID: 9303970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.
    Wistuba II; Behrens C; Milchgrub S; Bryant D; Hung J; Minna JD; Gazdar AF
    Oncogene; 1999 Jan; 18(3):643-50. PubMed ID: 9989814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
    Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
    Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
    Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
    Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
    Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
    Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
    Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.
    Sato M; Takahashi K; Nagayama K; Arai Y; Ito N; Okada M; Minna JD; Yokota J; Kohno T
    Genes Chromosomes Cancer; 2005 Dec; 44(4):405-14. PubMed ID: 16114034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.